JPH10507179A - 修飾ポリ不飽和脂肪酸 - Google Patents
修飾ポリ不飽和脂肪酸Info
- Publication number
- JPH10507179A JPH10507179A JP8512793A JP51279396A JPH10507179A JP H10507179 A JPH10507179 A JP H10507179A JP 8512793 A JP8512793 A JP 8512793A JP 51279396 A JP51279396 A JP 51279396A JP H10507179 A JPH10507179 A JP H10507179A
- Authority
- JP
- Japan
- Prior art keywords
- fatty acid
- polyunsaturated fatty
- oxa
- thia
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C409/00—Peroxy compounds
- C07C409/02—Peroxy compounds the —O—O— group being bound between a carbon atom, not further substituted by oxygen atoms, and hydrogen, i.e. hydroperoxides
- C07C409/04—Peroxy compounds the —O—O— group being bound between a carbon atom, not further substituted by oxygen atoms, and hydrogen, i.e. hydroperoxides the carbon atom being acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C409/00—Peroxy compounds
- C07C409/16—Peroxy compounds the —O—O— group being bound between two carbon atoms not further substituted by oxygen atoms, i.e. peroxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C409/00—Peroxy compounds
- C07C409/40—Peroxy compounds containing nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C409/00—Peroxy compounds
- C07C409/42—Peroxy compounds containing sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/60—Unsaturated compounds containing ether groups, groups, groups, or groups the non-carboxylic part of the ether being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/708—Ethers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fats And Perfumes (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 抗マラリアおよび/または好中球刺激活性を有するポリ不飽和脂肪 酸化合物であって、βオキサ、γオキサ、βチア、およびγチアからなる群から 選択された1または2の置換基を有し、18−25の炭素数および1−6の二重 結合を有する、ポリ不飽和脂肪酸化合物。 2. アミノ酸に結合し、ヒドロキシ、ヒドロペルオキシ、ペルオキシ、 カルボキシメチル置換基からなる群から選択されたさらなる置換基を含有する、 請求項1に記載のポリ不飽和脂肪酸化合物。 3. 20−25の炭素数および3−6の二重結合を有する、請求項1ま たは2に記載のポリ不飽和脂肪酸化合物。 4. n−3からn−6脂肪酸である、請求項1ないし3のいずれか1項 に記載のポリ不飽和脂肪酸化合物。 5. βオキサまたはβチア置換基を含有する3−4の二重結合を有し、 21の炭素数を有する、請求項1ないし4のいずれか1項に記載のポリ不飽和脂 肪酸化合物。 6. βオキサまたはγチア置換基を含有する3−4の二重結合を有し、 22の炭素数を有する、請求項1ないし4のいずれか1項に記載のポリ不飽和脂 肪酸化合物。 7. βチア置換基を含有する3−4の二重結合を有し、23の炭素数を 有する、請求項1ないし4のいずれか1項に記載のポリ不飽和脂肪酸化合物。 8. γチア置換基を含有する3−4の二重結合を有し、24の炭素数を 有する、請求項1ないし4のいずれか1項に記載のポリ不飽和脂肪酸化合物。 9. βオキサ置換基を含有する3−6の二重結合を有し、25の炭素数 を有する、請求項1ないし4のいずれか1項に記載のポリ不飽和脂肪酸化合物。 10. βチア置換基を含有する3−6の二重結合を有し、25の炭素数 を有する、請求項1ないし4のいずれか1項に記載のポリ不飽和脂肪酸化合物。 11. ωヒドロキシ置換基を有する、請求項1ないし10のいずれか1 項に記載のポリ不飽和脂肪酸化合物。 12. α−カルボキシメチル基、βチア置換基、3−6の二重結合、お よび23の炭素数を有する、請求項1ないし4のいずれか1項に記載のポリ不飽 和脂肪酸化合物。 13. カルボキシ末端を介してアミノ酸に共有結合する、請求項1ない し4のいずれか1項に記載のポリ不飽和脂肪酸化合物。 14. アスパラギン酸またはグリシンに共有結合する、請求項13に記 載のポリ不飽和脂肪酸化合物。 15. アルコールのO−H結合にカルベンがインサートされるように、 カルベンと不飽和脂肪酸アルコールを反応させることを含有する、不飽和オキサ 置換脂肪酸の製造方法。 16. 不飽和脂肪酸アルコールが、1−6の二重結合、および18−2 5の炭素数を有する、請求項15に記載の方法。 17. カルベンが、ジアゾ化合物の酢酸ロジウム触媒を介して合成され る、請求項15または16に記載の方法。 18. 不飽和βオキサ置換脂肪酸が製造される、請求項15ないし17 のいずれか1項に記載の方法。 18. 患者の炎症治療方法であって、1−6のシスまたはトランス二重 結合を有し、18−24の炭素数の炭素鎖を有するポリ不飽和脂肪酸のヒドロキ シ、ヒドロキシペルオキシ、またはペルオキシ誘導体を少なくとも1つ含有する 、抗炎症組成物を治療有効量、患者に投与することを含有する、炎症治療方法。 19. ポリ不飽和脂肪酸が、オキサまたはチア誘導体として、炭素鎖内 に酸素またはイオウ原子を含有する、請求項18に記載の方法。 20. ポリ不飽和脂肪酸が、C20:4n−6(5,8,11,14− エイコサテトラエン酸)、C20:5n−3(5,8,11,14,17−エイ コサペンタエン酸)、C22:6n−3(4,7,10,13,16,19−エ イコサヘキサエン酸)、およびアラキドン酸からなる群から選択される、請求項 18に記載の方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU8781 | 1983-05-05 | ||
AUPM8781A AUPM878194A0 (en) | 1994-10-13 | 1994-10-13 | Modified fatty acids in the treatment of inflammation |
AU9066 | 1994-10-26 | ||
AUPM9066A AUPM906694A0 (en) | 1994-10-26 | 1994-10-26 | Novel compounds for treating malaria and other diseases |
PCT/AU1995/000677 WO1996011908A1 (en) | 1994-10-13 | 1995-10-13 | Modified polyunsaturated fatty acids |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH10507179A true JPH10507179A (ja) | 1998-07-14 |
Family
ID=25644792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8512793A Pending JPH10507179A (ja) | 1994-10-13 | 1995-10-13 | 修飾ポリ不飽和脂肪酸 |
Country Status (9)
Country | Link |
---|---|
US (1) | US6376688B1 (ja) |
EP (1) | EP0869941B1 (ja) |
JP (1) | JPH10507179A (ja) |
KR (1) | KR100463709B1 (ja) |
CN (1) | CN1088058C (ja) |
AT (1) | ATE210640T1 (ja) |
CA (1) | CA2202503C (ja) |
DE (1) | DE69524639T2 (ja) |
WO (1) | WO1996011908A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003527364A (ja) * | 2000-03-03 | 2003-09-16 | ティア、メディカ、アクチスカベット | 新規脂肪酸類似体 |
JP2016537411A (ja) * | 2013-10-29 | 2016-12-01 | ディグニティ サイエンシス リミテッド | 15−ヒドロキシ脂肪酸誘導体の作製方法 |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000508645A (ja) * | 1996-04-12 | 2000-07-11 | ペプテック リミテッド | ポリ不飽和脂肪酸を使用する免疫病の治療方法 |
DE19649869A1 (de) * | 1996-12-02 | 1998-06-04 | Biotechnolog Forschung Gmbh | Ungesättigte aliphatische Carbonsäuren (Maracenine), Herstellungsverfahren und Mittel |
AUPQ291499A0 (en) * | 1999-09-17 | 1999-10-07 | Women's And Children's Hospital Adelaide | Novel nitro and sulphur containing compounds |
AU784116B2 (en) * | 1999-09-17 | 2006-02-09 | Peplin Biolipids Pty Ltd | Anti-cancer nitro- and thia-fatty acids |
NO20006008L (no) * | 2000-11-28 | 2002-05-29 | Thia Medica As | Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer |
US20030144219A1 (en) | 2001-11-15 | 2003-07-31 | Phinney Stephen Dodge | Formulations and methods for treatment or amelioration of inflammatory conditions |
AU2003235454A1 (en) * | 2002-06-14 | 2003-12-31 | Alcon, Inc. | Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders |
AU2003221707A1 (en) * | 2002-06-14 | 2003-12-31 | Alcon, Inc. | Topical use of hydroxyeicosatetraenoic acid compounds to treat psoriasis |
JP5008258B2 (ja) | 2002-06-20 | 2012-08-22 | アイシー・ベック・リミテッド | 含硫黄ホスホリピド誘導体 |
US20090215895A1 (en) * | 2004-01-30 | 2009-08-27 | Peplin Biolipids Pty Ltd | Therapeutic and carrier molecules |
US20090264586A1 (en) * | 2006-05-12 | 2009-10-22 | Nuplex Resins B.V. | Aqueous dispersion of an auto-oxidatively drying polyurethane |
BRPI0717972A2 (pt) * | 2006-11-01 | 2013-11-12 | Pronova Biopharma Norge As | Lipídeos de ômega-3 alfa-substituídos que são ativadores ou moduladores do receptor ativado por proliferadores de peroxissoma (ppar) |
WO2009006668A1 (en) * | 2007-02-05 | 2009-01-15 | Children, Youth And Women's Health Service | Modulators of antigen-dependent t cell proliferation |
US8324277B2 (en) | 2007-08-01 | 2012-12-04 | University of Pittsburgh—of the Commonwealth System of Higher Education | Nitrated-fatty acids modulation of type II diabetes |
CA2729053A1 (en) | 2008-05-01 | 2009-11-05 | Bruce A. Freeman | Vinyl substituted fatty acids |
GB2460056A (en) * | 2008-05-14 | 2009-11-18 | Arab Science & Technology Foun | Compositions comprising omega-6 fatty acids for use in treating schistosomiasis |
CN102099024B (zh) | 2008-06-19 | 2015-11-25 | 犹他大学研究基金会 | 硝化脂质在毒性医疗疗法的副作用的治疗上的用途 |
US20140024713A1 (en) | 2008-06-19 | 2014-01-23 | University Of Utah Research Foundation | Use of nitrated lipids for treatment of side effects of toxic medical therapies |
EP2147910A1 (en) * | 2008-07-15 | 2010-01-27 | Pronova BioPharma Norge AS | Novel lipid compounds |
EP2208720A1 (en) | 2009-01-13 | 2010-07-21 | Max-Delbrück-Centrum für Molekulare Medizin (MDC) | Novel eicosanoid derivatives |
AU2010244136B2 (en) | 2009-05-08 | 2016-05-12 | Pronova Biopharma Norge As | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas |
JP2013500966A (ja) | 2009-07-31 | 2013-01-10 | ユニバーシティー オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション | 抗炎症剤としての脂肪酸 |
EP2483233A4 (en) * | 2009-10-02 | 2013-08-14 | Complexa Inc | HETEROATOMA CONTAINING SUBSTITUTED FATTY ACIDS |
JP2014505017A (ja) | 2010-11-05 | 2014-02-27 | プロノヴァ・バイオファーマ・ノルゲ・アーエス | 脂質化合物を用いる処置方法 |
EP2744491B1 (en) | 2011-08-19 | 2020-07-29 | The University of Utah Research Foundation | Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system |
JP6537980B2 (ja) | 2013-02-28 | 2019-07-03 | プロノヴァ・バイオファーマ・ノルゲ・アーエスPronova BioPharma Norge AS | 脂質化合物、トリグリセリドおよび界面活性剤を含む組成物、ならびにその使用方法 |
CN115025079A (zh) | 2015-04-28 | 2022-09-09 | 普罗诺瓦生物医药挪威公司 | 结构增强的含硫脂肪酸在预防和/或治疗非酒精性脂肪性肝炎中的用途 |
DK3303339T3 (da) | 2015-07-07 | 2021-04-12 | H Lundbeck As | Pde9-inhibitorer med imidazotriazinonskelet og imidazopyrazinonskelet til behandling af perifere sygdomme |
EP3355879A4 (en) | 2015-10-02 | 2019-05-22 | Complexa, Inc. | PREVENTION, TREATMENT AND INVERSION OF DISEASE USING THERAPEUTICALLY EFFECTIVE AMOUNTS OF ACTIVATED FATTY ACIDS |
GB201521085D0 (en) * | 2015-11-30 | 2016-01-13 | Biozep As | Use |
WO2017223447A1 (en) * | 2016-06-23 | 2017-12-28 | The Regents Of The University Of Michigan | 12(s)-hydroxyeicosatrienoic acid compounds and their use as therapeutic agents |
WO2019111048A1 (en) | 2017-12-06 | 2019-06-13 | Basf As | Fatty acid derivatives for treating non-alcoholic steatohepatitis |
JP2021526134A (ja) | 2018-05-25 | 2021-09-30 | イマラ インク. | 6−[(3S,4S)−4−メチル−l−(ピリミジン−2−イルメチル)ピロリジン−3−イル]−3−テトラヒドロピラン−4−イル−7H−イミダゾ[l,5−A]ピラジン−8−オンの一水和物および結晶形態 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6372648A (ja) | 1986-09-16 | 1988-04-02 | Sumitomo Pharmaceut Co Ltd | 新規不飽和脂肪酸誘導体 |
GB8813012D0 (en) * | 1988-06-02 | 1988-07-06 | Norsk Hydro As | Non-b-oxidizable fatty acid analogues to reduce concentration of cholesterol & triglycerides in blood of mammals |
EP0591303B1 (en) | 1991-06-24 | 2000-12-06 | Women's And Children's Hospital | Methods and compositions for treating malaria and other diseases |
WO1994022848A1 (en) | 1993-03-29 | 1994-10-13 | Pace Asciak Cecil R | Hepoxilin analogs useful as anti-inflammatory agents |
US5767156A (en) | 1993-10-06 | 1998-06-16 | Peptide Technology Limited | Polyunsaturated fatty acids and uses thereof |
-
1995
- 1995-10-13 JP JP8512793A patent/JPH10507179A/ja active Pending
- 1995-10-13 KR KR1019970702434A patent/KR100463709B1/ko not_active IP Right Cessation
- 1995-10-13 WO PCT/AU1995/000677 patent/WO1996011908A1/en active IP Right Grant
- 1995-10-13 CA CA002202503A patent/CA2202503C/en not_active Expired - Fee Related
- 1995-10-13 DE DE69524639T patent/DE69524639T2/de not_active Expired - Lifetime
- 1995-10-13 US US08/817,430 patent/US6376688B1/en not_active Expired - Fee Related
- 1995-10-13 EP EP95933988A patent/EP0869941B1/en not_active Expired - Lifetime
- 1995-10-13 CN CN95196205A patent/CN1088058C/zh not_active Expired - Fee Related
- 1995-10-13 AT AT95933988T patent/ATE210640T1/de not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003527364A (ja) * | 2000-03-03 | 2003-09-16 | ティア、メディカ、アクチスカベット | 新規脂肪酸類似体 |
JP2016537411A (ja) * | 2013-10-29 | 2016-12-01 | ディグニティ サイエンシス リミテッド | 15−ヒドロキシ脂肪酸誘導体の作製方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1163609A (zh) | 1997-10-29 |
ATE210640T1 (de) | 2001-12-15 |
WO1996011908A1 (en) | 1996-04-25 |
CN1088058C (zh) | 2002-07-24 |
US6376688B1 (en) | 2002-04-23 |
EP0869941A1 (en) | 1998-10-14 |
DE69524639D1 (de) | 2002-01-24 |
EP0869941B1 (en) | 2001-12-12 |
DE69524639T2 (de) | 2002-08-08 |
CA2202503A1 (en) | 1996-04-25 |
KR970707088A (ko) | 1997-12-01 |
CA2202503C (en) | 2008-07-15 |
EP0869941A4 (ja) | 1998-10-14 |
KR100463709B1 (ko) | 2005-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH10507179A (ja) | 修飾ポリ不飽和脂肪酸 | |
US6262119B1 (en) | Methods of treating immunopathologies using polyunsaturated fatty acids | |
McCall et al. | Therapeutic potential of fish oil in the treatment of ulcerative colitis | |
RU2142468C1 (ru) | Эфиры холестерина и жирной кислоты, способ лечения и фармацевтическая или косметическая композиция | |
JP5827784B2 (ja) | ビタミンk2を含む医薬及び栄養補助製品 | |
US20050176816A1 (en) | Anti-inflammatory nitro- and thia-fatty acids | |
KR100382159B1 (ko) | 합성폴리불포화지방산유사체 | |
EP2324828A1 (en) | Treatment for neurodegenerative conditions | |
JP3284132B2 (ja) | 医薬組成物 | |
FR2532844A1 (fr) | Composition pharmaceutique contenant un compose polyprenylique | |
JP2016512544A (ja) | ドコサペンタエン酸を含む組成物、および使用方法 | |
ES2385940T3 (es) | Combinación para uso en el tratamiento de trastornos inflamatorios. | |
US4895872A (en) | Immunosupressive analogues and derivatives of succinylacetone | |
AU698476B2 (en) | Modified polyunsaturated fatty acids | |
JP5097043B2 (ja) | イオウ含有化合物、その調製方法および薬学的使用 | |
Camp | Cutaneous pharmacology: perspectives on the growth of investigation of mediators of inflammation | |
AU726798B2 (en) | Methods of treating immunopathologies using polyunsaturated fatty acids | |
JPH11246435A (ja) | 免疫調整剤 | |
US4510159A (en) | (+)-Cyanidan-3-ol derivatives, pharmaceutical preparations that contain such compounds, and the use of the latter to treat liver or venous diseases | |
US5252603A (en) | Immunosuppressive analogues and derivatives of succinylacetone | |
WO1990000049A2 (en) | Immunosuppressive analogues and derivatives of succinylacetone | |
Rutledge | The role of fatty acid oxidation in disruption of macrophage function | |
US5216005A (en) | Immunosuppressive analogues and derivatives of succinylacetone | |
JPH0153849B2 (ja) | ||
Albert et al. | Cyanidan-3-ol derivatives, pharmaceutical preparations that contain such compounds, and the use of the latter to treat liver or venous diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A72 | Notification of change in name of applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A721 Effective date: 20050526 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061017 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20060928 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070116 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070305 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070417 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070710 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071108 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20080207 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20080125 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080630 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20090108 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20090129 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090714 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090722 |